About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Chem-Geek Alternate History | Main | Merck and the Numbers »

May 22, 2006

Mid-day Update

Email This Entry

Posted by Derek

I know I have some people stopping by to see how the experiments I described on Saturday have turned out. Well, the runs that I did late last week were not kind to the instrument they ran through, so one of my colleagues is now trying to get the machine back to its usual state. I'm ready to go as soon as things look normal, which could be this afternoon. If not, I'll put everything in the freezer and we'll run 'em tomorrow. And yes, the suspense is getting to me.

Comments (3) + TrackBacks (0) | Category: Birth of an Idea


1. abel pharmboy on May 22, 2006 4:07 PM writes...

Still holding out for you on vial #33, Derek, although my wife gave me the bad news this weekend that Latrobe Brewing is being sold to Anheuser-Busch (for the uninitiated, the "33" legend is described in the last pgh of link). Let's hope you have better luck than the poor workers or, to look at it another way, that the contents of the vial move up the development/supply chain!

Permalink to Comment

2. anon on May 23, 2006 11:04 AM writes...

I especially like how the article portrays the beer as being trendy, when it was one of the cheapest that you could get at penn state. One of the local bars,, was famous for selling cases of pony bottles (9 oz?) of rolling rock. It is a shame that rolling rock had to sell out.

Good luck Derek.

Permalink to Comment

3. anon on May 26, 2006 11:01 AM writes...

The instrument is still down, and needs a part which has to be shipped from England. At least another week will pass until the samples can be analyzed.

(I am a colleague of Derek's.)

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry